Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.Recruiting
NCT05727904Phase 3Updated Jun 26, 2026
Sponsor: Iovance Biotherapeutics, Inc.
Metastatic Melanoma · Unresectable Melanoma · Melanoma
United States, Australia, Belgium, Canada, Finland +11 more
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGRecruiting
NCT04045665Phase 3Updated Jun 26, 2026
Sponsor: Icahn School of Medicine at Mount Sinai
Atrial Fibrillation · Stroke · Bleeding
United States, Brazil, Canada, Germany, United Kingdom
Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog AlfaRecruiting
NCT06716814Phase 3Updated Jun 26, 2026
Sponsor: Swedish Orphan Biovitrum
Haemophilia A (Moderate or Severe)
Bulgaria, France, Greece, Italy, Norway +2 more
Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast CancerRecruiting
NCT07669467Phase 3Updated Jun 25, 2026
Sponsor: Natureceuticals Sdn Bhd
Fatigue Related to Cancer Treatment · Breast Cancer
India
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA VariantsRecruiting
NCT06904261Phase 3Updated Jun 25, 2026
Sponsor: Amicus Therapeutics
Fabry Disease
United States, Belgium, Germany, Spain, United Kingdom
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive MedicationsRecruiting
NCT04877288Phase 3Updated Jun 25, 2026
Sponsor: Bristol-Myers Squibb
Renal Allograft Recipients
United States, Argentina, Belgium, France, Germany +5 more
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLCRecruiting
NCT07131319Phase 2, Phase 3Updated Jun 25, 2026
Sponsor: Second Affiliated Hospital of Nanchang University
Non-Small Cell Lung Cancer
China
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryRecruiting
NCT03180268Phase 3Updated Jun 25, 2026
Sponsor: NRG Oncology
Grade 2 Meningioma · Intracranial Meningioma
United States, Canada, India, Japan, Saudi Arabia
PKB171 Against Placebo in Couples With Mild Male Factor InfertilityRecruiting
NCT07669584Phase 2, Phase 3Updated Jun 25, 2026
Sponsor: Prokrea BCN, S.L.
Infertility Due to Azoospermia
Spain
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric AdenocarcinomasRecruiting
NCT06346197Phase 3Updated Jun 25, 2026
Sponsor: Centre Leon Berard
Gastric Cancer · MSI-H · Metastatic Cancer · Advanced Cancer
France
Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 TrialsRecruiting
NCT07668856Phase 3Updated Jun 25, 2026
Sponsor: UMC Utrecht
Refractory Epilepsy in Children · Refractory Epilepsy · Epilepsy
Netherlands
Study of Out of Specification for TisagenlecleucelRecruiting
NCT04094311Phase 3Updated Jun 25, 2026
Sponsor: Novartis Pharmaceuticals
B-cell Acute Lymphoblastic Leukemia · Diffuse Large B-cell Lymphoma
Canada, Japan
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.Recruiting
NCT07385703Phase 3Updated Jun 25, 2026
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Adenocarcinoma
China
Study of Cannabidiol in Sanfilippo SyndromeRecruiting
NCT06333041Phase 2, Phase 3Updated Jun 25, 2026
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Sanfilippo Syndrome · Mucopolysaccharidosis III
United States
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTingRecruiting
NCT06195540Phase 3Updated Jun 25, 2026
Sponsor: University Hospital, Angers
Venous Thromboembolism · Deep Vein Thrombosis · Pulmonary Embolism · Lower Limb Trauma
France
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaRecruiting
NCT06664619Phase 3Updated Jun 25, 2026
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Asthma
United States, Argentina, Bulgaria, Czechia, Germany +8 more
Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Stage IV Colon Cancer Patients Undergoing First-Line ChemotherapyRecruiting
NCT07669519Phase 3Updated Jun 25, 2026
Sponsor: Natureceuticals Sdn Bhd
Fatigue · Colon Cancer
India
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.Recruiting
NCT07669454Phase 3Updated Jun 25, 2026
Sponsor: Natureceuticals Sdn Bhd
Fatigue Related to Cancer Treatment · Colon Cancer
India
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerRecruiting
NCT05946213Phase 3Updated Jun 25, 2026
Sponsor: NRG Oncology
Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8
United States, Canada, Hong Kong, Switzerland
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous NephropathyRecruiting
NCT05696613Phase 3Updated Jun 25, 2026
Sponsor: Cerium Pharmaceuticals, Inc.
Primary Membranous Nephropathy
United States, Canada, India
Phase 3b Study in Patients With Severe Asthma Treated With TezepelumabRecruiting
NCT07363642Phase 3Updated Jun 25, 2026
Sponsor: AstraZeneca
Severe Asthma
China
Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-upRecruiting
NCT04290663Phase 3Updated Jun 25, 2026
Sponsor: Centre Francois Baclesse
Thyroid Cancer · Intermediate Risk
France
HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)Recruiting
NCT07379190Phase 3Updated Jun 25, 2026
Sponsor: Weifang Medical University
Stroke, Acute · Stroke, Ischemic · Cerebral Infarction
China
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)Recruiting
NCT06891443Phase 3Updated Jun 25, 2026
Sponsor: Laboratoires Thea
Leber Congenital Amaurosis 10 · Blindness · Leber Congenital Amaurosis · Sensation Disorders
United States, Belgium, Brazil, Canada, France +4 more
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-IberdomideRecruiting
NCT05558319Phase 3Updated Jun 25, 2026
Sponsor: PETHEMA Foundation
Newly Diagnosed Multiple Myeloma
Spain

Previous page Next page